Treatment of aseptic facial granuloma as a manifestation of pediatric rosacea with oral macrolides

Pediatr Dermatol. 2023 Nov-Dec;40(6):1064-1067. doi: 10.1111/pde.15420. Epub 2023 Sep 5.

Abstract

Aseptic facial granuloma is a rare pediatric disease, presenting with asymptomatic facial nodules on the cheeks or the eyelids and may represent a form of granulomatous rosacea in children. In this retrospective case series, 12 children with aseptic facial granuloma were treated with oral macrolides (erythromycin or roxithromycin) resulting in a healing of the lesions within a mean treatment time of 5.25 months with no recurrences. The treatment was mainly well tolerated. Oral macrolides may be effective in the treatment of patients with aseptic facial granuloma.

Keywords: aseptic facial granuloma; erythromycin; macrolides; rosacea; roxithromycin.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cheek / pathology
  • Child
  • Facial Dermatoses* / drug therapy
  • Facial Dermatoses* / pathology
  • Granuloma / drug therapy
  • Granuloma / pathology
  • Humans
  • Macrolides / therapeutic use
  • Retrospective Studies
  • Rosacea* / drug therapy

Substances

  • Macrolides
  • Anti-Bacterial Agents